Is United Therapeutics Corporation (UTHR) a Buy, Sell, or Hold?
United Therapeutics Corporation
NASDAQ:UTHR
$526.66 USD
-$8.91 (-1.66%)
- Volume
- 372.63K
- Average Volume
- 486.46K
- Market Capitalization
- $22.35B
- P/E Ratio
- 17.99
- Dividend Yield
- 0.00%
- Price Target
- $625.00
- Year High
- $609.35
- Year Low
- $272.12
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.79
Analyst Rating
Buy
4 Rating Score
UPSIDE/DOWNSIDE
-15.7% DOWNSIDE
$625.00 Price Target
UPSIDE/DOWNSIDE HIGH
-28.3% DOWNSIDE
$735.00 Price Target High
UPSIDE/DOWNSIDE LOW
2.1% UPSIDE
$516.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Morgan Stanley | Terence Flynn | $516 | $583.145 | 2026-05-07 09:29 AM | -11.5% |
| Morgan Stanley | Terence Flynn | $519 | $570.48 | 2026-04-10 08:54 AM | -9.0% |
| Cantor Fitzgerald | Olivia Brayer | $625 | $541.6041 | 2026-03-12 09:11 AM | 15.4% |
| H.C. Wainwright | Andrew Fein | $600 | $508.4749 | 2026-02-26 12:23 PM | 18.0% |
| Jefferies | Eun Yang | $575 | $476.59 | 2025-11-19 04:24 AM | 20.6% |
| H.C. Wainwright | Andrew Fein | $525 | $449.76 | 2025-10-30 09:34 AM | 16.7% |